Announcements Trials
Browse Landscape

Phase

Phase NA 24Phase 2 6Phase 1 5Phase EARLY_PHASE1 1Phase 4 1Phase 3 1Phase 2/3 1

Status

Unknown 2Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 2Gynecologic 1Gastrointestinal 1

Conditions

Premature Birth 1Hemangioma, Capillary 1Gynecologic Cancer 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Advanced Breast Cancer 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Population Groups × Clear all
NCT06770296 2025-01-13

The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase I Clinical Study

The First Affiliated Hospital with Nanjing Medical University

Phase 1 Recruiting
200 enrolled
Breast

Breast Neoplasms

NCT06290466 2024-03-04

Clinical Study on Pharmacokinetics of FCN-437c Capsule and Its Effect on QT Interval in Healthy Subjects

Ahon Pharmaceutical Co., Ltd.

Phase 1 Completed
18 enrolled
Breast

Advanced Breast Cancer

NCT05352646 2023-09-28

NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection

Newish Technology (Beijing) Co., Ltd.

Phase 1 Unknown
26 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01434849 2016-11-15

TiPPIH

The University of Texas Health Science Center at San Antonio

Phase 1 Terminated
26 enrolled

Hemangioma, Capillary, Premature Birth

NCT01304745 2013-07-09

Rehabilitation of Women Following Treatment for Gynaecological Cancer; a Randomized, Controlled Study

Haukeland University Hospital

Phase 1 Unknown
130 enrolled
Gynecologic

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡